Xiaodong Zhang

Director, Search & Evaluation, Oncology & Hematology Novartis AG

Xiaodong Zhang is in Business Development Search & Evaluation for Oncology and Hematology at Novartis, where she focuses on pipeline strategy and external innovation opportunities. She brings broad experience across strategy, R&D, commercialization, and business development, with deep expertise spanning U.S., China, and global markets. Prior to Novartis, she was a management consultant at McKinsey & Company, advising leading healthcare organizations on growth, portfolio strategy, and M&A. Xiaodong holds a PhD in Molecular and Cellular Biology from Harvard University and completed executive training at Harvard Business School.

Seminars

Tuesday 15th September 2026
Panel Discussion: Aligning Pharma Partnership Expectations Across Biotech & Academics to Encourage Successful Collaborations
1:30 pm
  • Identifying the ideal development stage for engagement to ensure timely and effective collaboration
  • Detailing therapies of interest, considering in vivo and beyond to identify high-value opportunities
  • Discussing collaboration processes beyond initial interest to secure
Xiaodong Zhang - Novartis - Expert Speaker at the 11th CAR-TCR Summit 2026